Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

Clinical trial NCT00255346 · COMPLETED

Trial details

NCT number: NCT00255346
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Agnogenic Myeloid Metaplasia Myelofibrosis Hypereosinophilic Syndrome Polycythemia Vera Mastocytosis Leukemia, Myelomonocytic, Chronic

Start date: 2005-11-15
Primary completion: 2017-03-03
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.